Trials / Completed
CompletedNCT03152123
Determination the Abuse Potential of Pitolisant in Healthy, Non-Dependent Recreational Stimulant Users
A Randomized, Double-Blind, Active- and Placebo-Controlled, Single-Dummy, 4-Way Crossover Study to Determine the Abuse Potential of Pitolisant Compared to Phentermine and Placebo, in Healthy, Non-Dependent Recreational Stimulant Users
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- Bioprojet · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the abuse potential of single doses of pitolisant relative to phentermine HCl and placebo, when administered to healthy, non-dependent, recreational stimulant users.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pitolisant | Pitolisant 40 mg or 240 mg (tablets over-capsuled) |
| DRUG | Placebos | tablets over-capsuled |
| DRUG | Phentermine | Phentermine 60 mg (capsule over-capsuled) |
Timeline
- Start date
- 2017-03-15
- Primary completion
- 2017-10-23
- Completion
- 2017-10-23
- First posted
- 2017-05-12
- Last updated
- 2017-11-13
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03152123. Inclusion in this directory is not an endorsement.